RE: CRAZY15 May 2020 10:52
Agreed, but what I believe is that further funding will now be opened up based on the announcement yesterday. Its going to follow it's peers that are too working on a treatment - although we have a product that is far more advanced in terms of testing.
Draw your attention to the update on 6th February, which advised Avion and ImmuPharma were to meet with the FDA in Q1 2020 to discuss guidance on a new optimised international Phase III trial protocol in connection with Lupuzor and the fact they had positive discussions with a number of potential commercial partners of Lupuzor™ outside of the US.
The update yesterday was another piece of the jigsaw - this has the potential to be lifechanging for holders - my view!